Article
Targeted fusion of Antibody-Secreting Cells: unlocking monoclonal antibody production with hybridoma technology
2025-03-19
Abstract excerpt
Monoclonal antibodies (mAbs) produced by hybridoma technology have extensively proved their value for therapeutic, diagnostic, and biomedical research applications, despite the reported low fusion yields between short-lived B cells and immortal myeloma cells. To improve the efficiency of this process and accelerate the development of new mAbs, we characterized and isolated antibody-secreting cells (ASCs) from the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ef8ab16-6984-5cfb-aaf7-ac504bab804c
- DOI
- 10.1101/2025.03.19.644155
